Bio Break: Helping Santa with Medical Innovations

Resources

Bio Break: Helping Santa with Medical Innovations

Topic: Bio Break

In this festive episode of Bio Break, Joris van der Heijden and Nick Allan bring a holiday twist to medical device innovation by discussing how modern technology could improve Santa’s health. Using a lighthearted analogy, they explore the challenges of managing conditions like diabetes and how advancements in drug delivery devices, such as Ozempic injection systems, could make a difference.

The conversation begins with Joris reflecting on Santa’s evolving image and the potential health risks of his iconic cookie-filled lifestyle. Nick introduces Ozempic, a GLP-1 receptor agonist that has gained widespread adoption for its effectiveness in managing diabetes and even its potential in preventing conditions like Alzheimer’s. While the medication itself is groundbreaking, the episode focuses on the delivery system and areas for improvement.

The experts highlight the limitations of current pre-filled syringes used for Ozempic, such as the need for precise dosage adjustments, proper disposal of sharps, and the overall user experience. They propose innovations that could make the medication more user-friendly, such as:

  • Auto-Injector Devices: Eliminating the need for manual dosing and reducing the margin for error.
  • Cartridge-Based Systems: Offering a simpler and safer method for home use, with fewer complications in terms of storage and handling.
  • Improved User Interfaces: Streamlining the experience for users like Santa, who may prefer a system requiring less technical input.

This holiday-themed episode underscores the importance of user-centric design in medical devices, particularly in enhancing the accessibility and safety of life-changing medications.

Whether you’re a medical device developer, healthcare innovator, or just looking for a fresh perspective on improving healthcare, this episode offers insights wrapped in holiday cheer. Discover how thoughtful design and innovation can make a difference for patients—and maybe even Santa Claus himself!

Helping Santa with Medical Innovations

Healthcare business and Medical examination, Doctor with icon medical with analyzing data

We all know medical devices have labels, but how often do we consider their purpose and the effort required to ensure they provide the right information? Device labelling serves as the interface between the manufacturer, the user, and regulatory bodies. (Note that being from Canada, we spell labelling with two Ls.)

Room for sterilization of medical instruments in a modern outpatient clinic

Sterilization is a critical process in the medical device industry as it provides a reliable way to ensure that devices are free from harmful microorganisms when they are used on patients. This blog talks about the categories of sterilization currently used on medical devices in manufacturing settings. It also addresses concerns surrounding the use of ethylene oxide (EtO), an indispensable method for sterilizing heat and moisture sensitive devices.

Female professional doctor showing medical test result explaining prescription using digital tablet app visiting senior woman patient at home sitting on sofa. Elderly people healthcare tech concept

Predicting the trends of a new year is always interesting and a bit unpredictable. We asked our medical device design and development professionals to submit their most interesting medtech trends for 2025 and the reasoning behind their prediction. The results were surprisingly focused on two major trends: Home Healthcare and Wearable Devices. Within these categories, several technologies were identified including edge computing, IoT, and connected devices. In no particular ranking, here are our 2025 predictions:  

Mammalogist doctor examines a woman breasts and lymph nodes during appointment. Skillful oncologist puncture of mammary glands of young patient under review ultrasound for diagnosis of breast cancer.

The U.S. Food and Drug Administration (FDA) and the Office for Human Research Protections (OHRP) have released a draft guidance document, Considerations for Including Tissue Biopsies in Clinical Trials, issued in January 2025. It provides recommendations for sponsors, investigators, institutions, and Institutional Review Boards (IRBs) on the safe and ethical incorporation of tissue biopsies in clinical trials.